Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Anthracycline and taxane containing chemotherapy for early-stage operable breast cancer: meta-analyses of 100,000 women in 86 randomised trials

Taylor CAROLYN. et al, (2023), The Lancet

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

(2022), The Lancet, 399, 1941 - 1953

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.

WHO Solidarity Trial Consortium None. et al, (2021), N Engl J Med, 384, 497 - 511

Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results

PAN H. and Peto R., (2020), MedRxiv

Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors.

Mappin-Kasirer B. et al, (2020), Neurology, 94, e2132 - e2138

Timing of procedural stroke and death in asymptomatic patients undergoing carotid endarterectomy: analysis of VACS, ACAS, ACST-1 and GALA RCTs

Poorthuis M. et al, (2019), British Journal of Surgery

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H. et al, (2017), N Engl J Med, 377, 1836 - 1846

A novel clinical risk score to identify people with asymptomatic carotid artery stenosis with a higher risk of stroke

Halliday AW. et al, (2017)

Pre-operative Carotid Plaque Echolucency Assessment has no Predictive Value for Long-Term Risk of Stroke or Cardiovascular Death in Patients Undergoing Carotid Endarterectomy.

de Waard D. et al, (2017), Eur J Vasc Endovasc Surg, 54, 135 - 141

10 vs 5 years of adjuvant tamoxifen: exclusion of 1/402 centres in ATLAS.

Davies C. et al, (2017), Lancet, 389

Ten-year risk of stroke in patients with previous cerebral infarction and the impact of carotid surgery in the Asymptomatic Carotid Surgery Trial.

Streifler JY. et al, (2016), Int J Stroke, 11, 1020 - 1027

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2015), Lancet, 386, 1353 - 1361

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2015), Lancet, 386, 1341 - 1352

Risk of stroke from new carotid artery occlusion in the Asymptomatic Carotid Surgery Trial-1.

den Hartog AG. et al, (2013), Stroke, 44, 1652 - 1659

Include forthcoming?